Skip to content
Clinical Trials – home

Methotrexate: A Versatile Medication for Various Conditions

44 / 79
trials open to patients / all trials
24+
Countries

In short

Methotrexate is a versatile drug that has been the subject of numerous clinical trials for treating various medical conditions. This article explores the use of methotrexate in clinical studies for conditions such as rheumatoid arthritis, psoriasis, ectopic pregnancy, and gestational trophoblastic neoplasia. We'll examine the drug's efficacy, safety, and potential new applications as revealed by recent clinical research.

What is Methotrexate?

Methotrexate is a versatile medication used to treat various conditions. It is known by several other names, including MTX, amethopterin, and Trexall®. Methotrexate belongs to a class of drugs called antimetabolites, which work by interfering with the growth of certain cells in the body.

Conditions Treated with Methotrexate

Methotrexate is used to treat a wide range of conditions, including:

  • Rheumatoid Arthritis: A chronic inflammatory disorder affecting the joints
  • Crohn's Disease: A type of inflammatory bowel disease
  • Certain types of cancer: Including leukemia, lymphoma, and ovarian cancer
  • Large Granular Lymphocyte (LGL) Leukemia: A rare type of blood cancer
  • Alopecia Areata: An autoimmune disorder causing hair loss
  • Colorectal Cancer: When used in combination with other medications

How Methotrexate Works

Methotrexate works in different ways depending on the condition being treated:

  • For cancer: It interferes with the growth of cancer cells, stopping them from dividing and multiplying.
  • For autoimmune conditions: It suppresses the immune system, reducing inflammation and slowing down the progression of the disease.
  • For LGL Leukemia: It helps normalize blood cell counts and reduce symptoms associated with the disease.

How Methotrexate is Administered

Methotrexate can be administered in several ways:

  • Oral tablets: Taken by mouth, often on a weekly basis
  • Injections: Given under the skin (subcutaneous) or into a muscle
  • Intravenous infusion: Delivered directly into a vein

The dosage and frequency of administration depend on the condition being treated and the patient's response to the medication. For example, in rheumatoid arthritis, a common dosage is 7.5-25 mg per week.

Methotrexate in Combination Therapies

Methotrexate is often used in combination with other medications to enhance its effectiveness:

  • With biological drugs like infliximab or ocrelizumab for rheumatoid arthritis
  • As part of a "metronomic" chemotherapy regimen for colorectal cancer, combined with drugs like capecitabine, cyclophosphamide, and celecoxib
  • With sirolimus for certain types of leukemia and lymphoma

Potential Side Effects

Like all medications, methotrexate can cause side effects. Common side effects may include:

  • Nausea and vomiting
  • Fatigue
  • Mouth sores
  • Increased risk of infections
  • Liver function abnormalities

To minimize side effects, doctors often prescribe folic acid supplements to patients taking methotrexate. It's important to discuss potential side effects with your healthcare provider and report any unusual symptoms promptly.

Ongoing Research and Future Directions

Researchers continue to study methotrexate to find new uses and improve its effectiveness:

  • Investigating its use in combination with other drugs for various types of cancer
  • Exploring its effectiveness in treating alopecia areata (hair loss)
  • Studying different dosing regimens to optimize treatment for conditions like LGL leukemia

These ongoing studies aim to expand our understanding of methotrexate and improve treatment outcomes for patients with various conditions.

Questions people often ask

Conditions where Methotrexate is being studied

Each condition opens its own overview and trial list

Trials with Methotrexate

Recruiting trials first

See all 79 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).